| High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours H Carén, F Abel, P Kogner, T Martinsson Biochemical Journal 416 (2), 153-159, 2008 | 363 | 2008 |
| Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2 C Krona, K Ejeskär, F Abel, P Kogner, J Bjelke, E Björk, RM Sjöberg, ... Oncogene 22 (15), 2343-2351, 2003 | 98 | 2003 |
| Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2 (SSTR2) gene at 17q24 F Abel, K Ejeskär, P Kogner, T Martinsson British journal of cancer 81 (8), 1402-1409, 1999 | 77 | 1999 |
| Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes K Thorell, A Bergman, H Carén, S Nilsson, P Kogner, T Martinsson, F Abel BMC medical genomics 2, 1-13, 2009 | 62 | 2009 |
| Analyses of apoptotic regulators CASP9 and DFFA at 1P36. 2, reveal rare allele variants in human neuroblastoma tumours F Abel, RM Sjöberg, K Ejeskär, C Krona, T Martinsson British journal of cancer 86 (4), 596-604, 2002 | 62 | 2002 |
| Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma D Astuti, M Morris, C Krona, F Abel, D Gentle, T Martinsson, P Kogner, ... British journal of cancer 91 (10), 1835-1841, 2004 | 61 | 2004 |
| The Phox2 pathway is differentially expressed in neuroblastoma tumors, but no mutations were found in the candidate tumor suppressor gene PHOX2A A Wilzén, S Nilsson, RM Sjöberg, P Kogner, T Martinsson, F Abel International journal of oncology 34 (3), 697-705, 2009 | 56 | 2009 |
| Fine mapping of a tumour suppressor candidate gene region in 1p36. 2‐3, commonly deleted in neuroblastomas and germ cell tumours K Ejeskär, RM Sjöberg, F Abel, P Kogner, PF Ambros, T Martinsson Medical and Pediatric Oncology: The Official Journal of SIOP—International …, 2001 | 56 | 2001 |
| Imbalance of the mitochondrial pro-and anti-apoptotic mediators in neuroblastoma tumours with unfavourable biology F Abel, RM Sjöberg, S Nilsson, P Kogner, T Martinsson European Journal of Cancer 41 (4), 635-646, 2005 | 48 | 2005 |
| Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer E Karlsson, U Delle, A Danielsson, B Olsson, F Abel, P Karlsson, K Helou Bmc Cancer 8, 1-14, 2008 | 47 | 2008 |
| Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36. 3→ p36. 2, but absence of mutations in primary tumors K Ejeskär, F Abel, RM Sjöberg, J Bäckström, P Kogner, T Martinsson Cytogenetics and cell genetics 89 (1-2), 62-66, 2000 | 47 | 2000 |
| A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma TT Tomić, J Olausson, A Wilzén, M Sabel, K Truvé, H Sjögren, S Dósa, ... PLoS One 12 (4), e0175638, 2017 | 41 | 2017 |
| Prevalence of germline mutations in patients with pheochromocytoma or abdominal paraganglioma and sporadic presentation: a population-based study in Western Sweden A Muth, F Abel, S Jansson, O Nilsson, H Ahlman, B Wängberg World journal of surgery 36, 1389-1394, 2012 | 36 | 2012 |
| A 6-gene signature identifies four molecular subgroups of neuroblastoma F Abel, D Dalevi, M Nethander, R Jörnsten, K De Preter, J Vermeulen, ... Cancer cell international 11, 1-15, 2011 | 35 | 2011 |
| Mutations in the N-terminal domain of DFF45 in a primary germ cell tumor and in neuroblastoma tumors F Abel, RM Sjöberg, C Krona, S Nilsson, T Martinsson International journal of oncology 25 (5), 1297-1302, 2004 | 35 | 2004 |
| Malignant pheochromocytomas/paragangliomas harbor mutations in transport and cell adhesion genes A Wilzén, A Rehammar, A Muth, O Nilsson, T Tešan Tomić, B Wängberg, ... International journal of cancer 138 (9), 2201-2211, 2016 | 33 | 2016 |
| A novel 1p36. 2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma tumours C Krona, K Ejeskär, H Carén, F Abel, RM Sjöberg, T Martinsson British journal of cancer 91 (6), 1119-1130, 2004 | 29 | 2004 |
| Expression of TWEAK/Fn14 in neuroblastoma: implications in tumorigenesis I Pettersen, N Baryawno, F Abel, WH Bakkelund, SN Zykova, JO Winberg, ... International journal of oncology 42 (4), 1239-1248, 2013 | 27 | 2013 |
| Stage-dependent expression of PI3K/Akt‑pathway genes in neuroblastoma S Fransson, F Abel, P Kogner, T Martinsson, K Ejeskär International journal of oncology 42 (2), 609-616, 2013 | 26 | 2013 |
| ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours A Wilzén, C Krona, B Sveinbjörnsson, E Kristiansson, D Dalevi, I Øra, ... Molecular cancer 12, 1-15, 2013 | 22 | 2013 |
